Chi D. Chu

Chi Chu practices at Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA.

Chi Chu's NPI, 1346651270, was assigned on May 14, 2014. Chi Chu graduated from UMass Chan Medical School in 2014. Chi Chu holds California license A141056.

Chi Chu's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center, at 1001 Potrero Avenue, San Francisco, CA 94110 in San Francisco County. The practice phone is (415) 206-8000.

Chi Chu's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA. The medical group on file is UCSF Pediatrics. Dmand AI also links Chi Chu to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Chi Chu practices. Vendor and product names are available with a free account.

Nephrology is Chi Chu's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Chi Chu is board certified in internal medicine by the American Board of Internal Medicine. Chi Chu is licensed in California.

CMS data shows 211 Medicare services from Chi Chu across 4 procedure codes in 2024, for 66 Medicare patients. Medicare paid $19,455 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 66 Medicare patients who saw Chi Chu in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. Their average risk score is 8.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Chi Chu's median patient age at 65, with 50% women.

In 2024, Chi Chu wrote 154 Medicare Part D claims for 34 patients. 82% of them were for generic drugs. CMS names the drug for 69 of them, across 4 drugs with 11 or more claims each, at $21,203 in total drug cost. In 2023, CMS named 100 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Chi Chu for performance year 2024, reported as part of a group. Chi Chu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 25 papers to Chi Chu, published from 2019 to 2024. 2023 was the busiest year, with 7. The most frequent topics are Renal Insufficiency, Chronic, Albuminuria and Glomerular Filtration Rate. Chi Chu has published most often in Kidney Med. Chi Chu's most frequent co-authors are Delphine Sonya Tuot, MD, Michelle Mae Estrella, MD and Michael George Shlipak, MD.

CMS Open Payments shows 20 general payments to Chi Chu from 7 drug and device companies from 2019 to 2024. Consulting fees make up the largest share, 71% of the total. Eli Lilly and Company paid the most, $4,383.

Chi Chu graduated from UMass Chan Medical School in 2014.

Chi Chu is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.